0000000000039699

AUTHOR

Jaime Signes-costa

showing 18 related works from this author

SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

2020

Background The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic events in COVID-19 patients has been suggested. By using several experimental approaches, we investigated the potential association between SARS-CoV-2 IgGs recognizing the spike (S) protein receptor-binding domain (RBD), neutralizing antibodies (NtAb) targeting S, and COVID-19 severity. Patients and methods This unicenter, retrospective, observational study included 51 hospitalized patients (24 at the intensive care unit; ICU). A total of 93 sera from these patients collected at different time points from the onset of symptoms were analyzed. SARS-CoV-2 RBD IgGs were quantitated by ELISA and NtAb50 titers wer…

0301 basic medicineMaleAntibodies ViralSeverity of Illness IndexGastroenterologylaw.invention0302 clinical medicinelaw030212 general & internal medicinebiologyInflammatory biomarkersMiddle AgedIntensive care unitHospitalizationTiterInfectious DiseasesSpike Glycoprotein CoronavirusFemaleAntibodyCoronavirus InfectionsAdultmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030106 microbiologyPneumonia ViralNeutralizing antibodiesArticleVirus03 medical and health sciencesBetacoronavirusYoung AdultVirologyInternal medicineSeverity of illnessmedicineHumansPandemicsAgedRetrospective StudiesInflammationbusiness.industrySARS-CoV-2C-reactive proteinCOVID-19Retrospective cohort studyAntibodies NeutralizingFerritinbiology.proteinBinding Sites AntibodybusinessBiomarkers
researchProduct

Declaración Oficial de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) sobre cigarrillos electrónicos e IQOS®

2019

Resumen El uso de productos del tabaco novedosos, en especial el cigarrillo electronico y los dispositivos de combustion parcial de tabaco (sistemas Heat not Burn), han aumentado de forma exponencial, sobre todo en jovenes y adolescentes. Las autoridades sanitarias y las sociedades cientificas han mostrado preocupacion ante las dudas que existen sobre su seguridad y eficacia (como metodo de abandono del tabaco). Tras el estudio de la evidencia cientifica disponible no es posible asegurar la inocuidad de los vapores o humos que inhalan los usuarios de estos dispositivos. Respecto a la eficacia no pueden recomendarse tras los resultados contradictorios de diferentes ensayos clinicos y metaana…

Pulmonary and Respiratory Medicine03 medical and health sciences0302 clinical medicine030228 respiratory systembusiness.industryMedicinebusinessHumanitiesArchivos de Bronconeumología
researchProduct

Ventilación no invasiva y foramen oval: una causa de hipoxemia paradójica

2020

lcsh:RC705-779business.industryMedicinelcsh:Diseases of the respiratory systembusinessOpen Respiratory Archives
researchProduct

Economic Evaluation Of Hospital Admissions For Patients With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtybusiness.industryEconomic evaluationmedicinePulmonary diseaseIntensive care medicinebusinessB47. COPD EXACERBATIONS: MISCELLANEOUS
researchProduct

Underlying heart diseases and acute COVID-19 outcomes

2021

Background: The presence of any underlying heart condition could influence outcomes during the coronavirus disease 2019 (COVID-19). Methods: The registry HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19, NCT04334291) is an international ambispective study, enrolling COVID-19 patients discharged from hospital, dead or alive. Results: HOPE enrolled 2798 patients from 35 centers in 7 countries. Median age was 67 years (IQR: 53.0-78.0), and most were male (59.5%). A relevant heart disease was present in 682 (24%) cases. These were older, more frequently male, with higher overall burden of cardiovascular risk factors (hypertension, dyslipidemia, diabetes mellitus, smoking habit, …

Malemedicine.medical_specialtyHeart DiseasesHeart diseaseInfecciones por coronavirusEnfermedad cardiovascularEnfermedad transmisibleheart diseaseComorbidityregistry030204 cardiovascular system & hematologyGlobal HealthSepsis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineTocilizumabRisk FactorsDiabetes mellitusInternal medicinemedicineHumansRegistriesPandemicsAgedRetrospective StudiesSARS-CoV-2business.industryCOVID-19HydroxychloroquineGeneral MedicineMiddle AgedPrognosismedicine.diseasemortalitychemistrycardiologyHeart failureCohortCardiologyFemaleCardiology and Cardiovascular MedicinebusinessDyslipidemiamedicine.drugCardiology Journal
researchProduct

Outpatient Treatment And Community Acquired Pneumonia (CAP): A Comparative Study With Hospital Admission

2011

medicine.medical_specialtyCommunity-acquired pneumoniabusiness.industryEmergency medicineHospital admissionmedicineMedical emergencymedicine.diseasebusinessC55. RISK FACTORS, PROGNOSIS, AND MANAGEMENT OF BACTERIAL PNEUMONIA
researchProduct

Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19

2020

This study aimed to assess the time course of circulating neutrophil and lymphocyte counts and their ratio (NLR) in ST-segment elevation myocardial infarction (STEMI) and coronavirus disease (COVID)-19 and explore their associations with clinical events and structural damage. Circulating neutrophil, lymphocyte and NLR were sequentially measured in 659 patients admitted for STEMI and in 103 COVID-19 patients. The dynamics detected in STEMI (within a few hours) were replicated in COVID-19 (within a few days). In both entities patients with events and with severe structural damage displayed higher neutrophil and lower lymphocyte counts. In both scenarios, higher maximum neutrophil and lower mi…

LymphocyteCelllcsh:MedicineseverityDiseaselymphocyte030204 cardiovascular system & hematologymedicine.disease_causeArticle03 medical and health sciences0302 clinical medicineImmune systemneutrophilsmedicinecardiovascular diseasesMyocardial infarction030304 developmental biologyCoronavirus0303 health sciencesbusiness.industrylcsh:RCOVID-19General Medicinemedicine.diseaseAcquired immune systemNeutrophiliamyocardial infarctionmedicine.anatomical_structureImmunologyprognosismedicine.symptombusinessJournal of Clinical Medicine
researchProduct

Hypoxic burden and angiogenic factors in patients with myocardial infarction and obstructive sleep apnea

2019

Introduction: The amount and severity of hypoxia have been related to risk of cardiovascular events. Aim: To determine the relationship between nocturnal hypoxic burden and pro- angiogenic factors in patients with obstructive sleep apnea (OSA) and myocardial infarction (MI). Method: A prospective, observational study in patients with a first acute MI. Eligible patients underwent a polysomnography within 30 days after MI, and a serum blood sample was drawn in order to measure a panel of angiogenic factors by Luminex technology. A hypoxic burden index (HBI) was calculated as the integral area under the desaturation curve (obtained by calculating the integral of the oxygen saturation reduction…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryPolysomnographyHypoxia (medical)medicine.diseaseSleep timeObstructive sleep apneaInternal medicineparasitic diseasesmedicineCardiologyIn patientObservational studyMyocardial infarctionmedicine.symptombusinessOxygen saturation (medicine)Sleep and control of breathing
researchProduct

Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis

2021

BackgroundSmoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established.MethodsWe included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included following an in-hospital admission with a COVID-19 diagnosis. We analysed the outcomes of patients with a current or prior history of smoking compared with the non-smoking group. The primary …

2474medicine.medical_specialtyRC620-627Health (social science)Coronavirus disease 2019 (COVID-19)infectious diseaseMedicine (miscellaneous)Health outcomesSepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointRisk of mortality1506030212 general & internal medicineNutritional diseases. Deficiency diseasesOriginal Researchpulmonary diseaseNutrition and Dieteticsbusiness.industry2524Clinical courseCOVID-19medicine.diseaseFormer Smoker030228 respiratory systemSmoking statusbusinessBMJ Nutrition, Prevention & Health
researchProduct

SARS‐CoV‐2‐reactive interferon‐γ‐producing CD8+ T cells in patients hospitalized with coronavirus disease 2019

2020

Abstract There is limited information on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) T‐cell immune responses in patients with coronavirus disease 2019 (COVID‐19). Both CD4+ and CD8+ T cells may be instrumental in resolution of and protection from SARS‐CoV‐2 infection. Here, we tested 25 hospitalized patients either with microbiologically documented COVID‐19 (n = 19) or highly suspected of having the disease (n = 6) for presence of SARS‐CoV‐2‐reactive CD69+ expressing interferon‐γ (IFN‐γ) producing CD8+ T cells using flow‐cytometry for intracellular cytokine staining assay. Two sets of overlapping peptides encompassing the SARS‐CoV‐2 Spike glycoprotein N‐terminal 1 to 643 am…

MaleMyeloma proteinCD8-Positive T-LymphocytesAntibodies ViralLymphocyte ActivationCD8+ T cellsSARS‐CoV‐2Blood cell03 medical and health sciencesInterferon-gamma0302 clinical medicineImmune systemAntigenCOVID‐19Intensive careVirologyCytotoxic T cellMedicineHumans030212 general & internal medicineResearch ArticlesAgedAged 80 and overbiologybusiness.industryfungiCOVID-19T‐cell immunityMiddle AgedVirologyHospitalizationmedicine.anatomical_structureInfectious DiseasesImmunoglobulin GSpike Glycoprotein Coronavirusbiology.protein030211 gastroenterology & hepatologyFemaleAntibodybusinessCD8Preliminary DataResearch ArticleJournal of Medical Virology
researchProduct

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

2022

In the lungs, fibrosis is a growing clinical problem that results in shortness of breath and can end up in respiratory failure. Even though the main fibrotic disease affecting the lung is idiopathic pulmonary fibrosis (IPF), which affects the interstitial space, there are many fibrotic events that have high and dangerous consequences for the lungs. Asthma, chronic obstructive pulmonary disease (COPD), excessive allergies, clearance of infection or COVID-19, all are frequent diseases that show lung fibrosis. In this review, we describe the different kinds of fibrosis and analyse the main types of cells involved—myofibroblasts and other cells, like macrophages—and review the main fibrotic mec…

Aparell respiratori MalaltiesMedicine (miscellaneous)General Biochemistry Genetics and Molecular BiologyPulmons MalaltiesBiomedicines
researchProduct

Official Statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Electronic Cigarettes and IQOS®.

2019

The use of novel tobacco products, particularly the electronic cigarette (EC) and partial tobacco combustion devices (HnB systems: Heat not Burn), has increased exponentially, particularly among adolescents and young people. The health authorities and scientific societies have shown concern about issues surrounding safety and effectiveness (as a method of smoking cessation). A study of the available scientific evidence has concluded that the safety of the vapor or fumes inhaled by the users of these devices cannot be guaranteed. Contradictory results from various clinical trials and meta-analyses also mean that these devices cannot be recommended for their effectiveness in cessation, especi…

medicine.medical_specialtymedicine.medical_treatmentRespiratory SystemElectronic Nicotine Delivery Systemslaw.inventionScientific evidence03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawInternal medicineNeoplasmsmedicinePulmonary MedicineHumansVareniclineSocieties MedicalBupropionAerosolsbusiness.industryThoracic SurgeryGeneral MedicineNicotine replacement therapyTobacco Use Cessation DevicesClinical trialPulmonology030228 respiratory systemchemistryCardiovascular DiseasesSpainFamily medicineSmoking cessationSmoking CessationbusinessElectronic cigarettemedicine.drugArchivos de bronconeumologia
researchProduct

Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia.

2020

ABSTRACTThere is scarce information on the frequency of co-detection of respiratory pathogens (RP) in patients with Covid-19. Documentation of coinfections in Covid-19 pneumonia patients may be relevant for appropriate clinical and therapeutic management of patients. Between March 4th and March 28th, 2020, a total of 183 adult patients testing positive by SARS CoV-2 RT-PCR on respiratory specimens were hospitalized with interstitial pneumonia at our center, of whom 103 were tested for other RP by a multiplexed PCR assay. Three patients had a positive result for either one (n=2; Coronavirus HKU1 or Mycoplasma pneumoniae) or two targets (n=1; Influenza virus A (H3) and Respiratory syncytial v…

AdultMalemedicine.medical_specialtyMycoplasma pneumoniaeRespiratory SystemOropharynxNosemedicine.disease_causeVirusTertiary Care Centers03 medical and health sciences0302 clinical medicineVirologyInternal medicinemedicineHumansIn patient030212 general & internal medicineRespiratory systemCoronavirusAgedbusiness.industryCoinfectionCOVID-19Middle Agedmedicine.diseaseVirologyRespiratory pathogensHospitalizationPneumoniaInfectious DiseasesItalyVirusesComputingMethodologies_DOCUMENTANDTEXTPROCESSING030211 gastroenterology & hepatologyFemaleViral diseasebusinessJournal of medical virologyREFERENCES
researchProduct

Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients

2021

ABSTRACTObjectivesThere is an imperative need to determine the durability of adaptive immunity to SARS-CoV-2. We enumerated SARS-CoV-2-reactive CD4+ and CD8+ T cells targeting S1 and M proteins and measured RBD-specific serum IgG over a period of 2-6 months after symptoms onset in a cohort of subjects who had recovered from severe clinical forms of COVID-19.MethodsWe recruited 58 patients (38 males and 20 females; median age, 62.5 years), who had been hospitalized with bilateral pneumonia, 60% with one or more comorbidities. IgG antibodies binding to SARS-CoV-2 RBD were measured by ELISA. SARS-CoV-2-reactive CD69+-expressing-IFNγ-producing-CD4+ and CD8+ T cells were enumerated in heparinize…

Malemedicine.medical_specialtyT cellsCD8-Positive T-LymphocytesAntibodies ViralGastroenterologyArticleFlow cytometryImmune systemImmunityVirologyInternal medicineHumansMedicineWhole bloodReceptor binding domain-specific IgG antibodiesmedicine.diagnostic_testbiologybusiness.industrySARS-CoV-2CD69ImmunityCOVID-19Middle AgedAcquired immune systemInfectious DiseasesCohortbiology.proteinFemaleAntibodybusinessCD8Journal of Clinical Virology
researchProduct

SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with Coronavirus viral disease-2019

2020

There is limited information on SARS-CoV-2 T-cell immune responses in patients with Covid-19. Both CD4+ and CD8+ T cells may be instrumental in the resolution of and protection from SARS-CoV-2 infection. Here, we tested 25 hospitalized patients with either microbiologically documented Covid-19 (n=19) or highly suspected of having the disease (n=6) for the presence of SARS-CoV-2-reactive- CD69+-expressing interferon-gamma;-producing-(IFN-gamma;) CD8+ T cells by a flow-cytometry for intracelular cytokine staining assay. Two sets of overlapping peptides encompassing the SARS-CoV-2 Spike glycoprotein N-terminal 1-643 amino acid sequence and the entire sequence of SARS-CoV-2 M protein were used …

business.industrymedicine.medical_treatmentfungiBlood cellCytokineImmune systemmedicine.anatomical_structureAntigenIntensive careImmunologyMedicineCytotoxic T cellViral diseasebusinessCD8
researchProduct

Efficacy Of Varenicline In Smokers With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtychemistry.chemical_compoundchemistrybusiness.industryInternal medicinemedicinePulmonary diseaseVareniclinebusinessB46. INHALED AND SYSTEMIC ANTI-INFLAMMATORY THERAPY IN COPD
researchProduct

Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis

2021

Abstract Treatment with Dextromethorphan/Quinidine (DM/Q) has demonstrated benefit on pseudobulbar affect and bulbar function in amyotrophic lateral sclerosis (ALS). The aim of this study was to assess whether DM/Q could provide long-term improvement in bulbar function and thereby prolong noninvasive respiratory management in ALS. Materials and methods This prospective, case-cohort study, recruited ALS patients with bulbar dysfunction. Subjects included were compared with cross-matched historical controls. Cases received DM/Q (20/10 mg twice daily) during one-year follow-up; bulbar dysfunction was evaluated with the Norris scale bulbar subscore (NBS) and bulbar subscale of AlSFRS-R (ALSFRSb…

MalePulmonary and Respiratory MedicineQuinidinemedicine.medical_specialtyTime FactorsPseudobulbar affectDextromethorphan/QuinidineDextromethorphanGastroenterologyBulbar dysfunctionInternal medicinemedicineRespiratory muscleHumansProspective StudiesAmyotrophic lateral sclerosisRespiratory systemAgedbusiness.industryAmyotrophic Lateral SclerosisDextromethorphanMiddle Agedmedicine.diseaseQuinidineTreatment OutcomeDrug Therapy CombinationFemalemedicine.symptomRespiratory InsufficiencybusinessFollow-Up Studiesmedicine.drugRespiratory Medicine
researchProduct

Mechanical Insufflation-Exsufflation With Oscillations in Amyotrophic Lateral Sclerosis With Home Ventilation via Tracheostomy

2020

BACKGROUND: Mechanical insufflation-exsufflation (MI-E) applied via tracheostomy tubes in patients with amyotrophic lateral sclerosis (ALS) who are on home mechanical ventilation via tracheostomy is an effective procedure for respiratory secretion management. Nonetheless, tenacious secretions may remain and increase the risk of respiratory infections. The aim of this study was to determine whether adding oscillations to MI-E could reduce the rate of respiratory infections and the need for bronchoscopy to remove secretions in patients with ALS on home mechanical ventilation via tracheostomy. METHODS: This was a 2-y, prospective, crossover study. Subjects were treated with conventional MI-E a…

Pulmonary and Respiratory MedicineMechanical ventilationInsufflationmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentGeneral MedicineCritical Care and Intensive Care MedicineBronchoscopies03 medical and health sciences0302 clinical medicine030228 respiratory systemRespiratory failureBronchoscopyInterquartile rangeAnesthesiamedicineExsufflationRespiratory systembusinessRespiratory Care
researchProduct